Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-08-08 Purchase | 2022-08-10 8:49 pm | Poseida Therapeutics Inc. | PSTX | Malin Life Sciences Holdings Ltd 10% Owner | 2,150,000 | $3.5 | $7,525,000 | 11,835,673 (Direct) | View |
| 2022-08-08 Purchase | 2022-08-10 6:13 pm | Poseida Therapeutics Inc. | PSTX | Ostertag Eric Executive Chairman 10% Owner | 142,857 | $3.5 | $500,000 | 9,398,519 (Indirect Direct) | View |
| 2022-08-03 Sale | 2022-08-05 4:09 pm | Poseida Therapeutics Inc. | PSTX | Ostertag Eric Executive Chairman 10% Owner | 160,696 | $3.689 | $592,808 | 9,255,662 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-17 Option Award | 2024-06-18 4:16 pm | N/A 2034-06-16 | Poseida Therapeutics Inc. | PSTX | Schmid John P. Director | 47,000 | $0 | 86,300 (Direct) | View |
| 2024-06-17 Option Award | 2024-06-18 4:16 pm | N/A 2034-06-16 | Poseida Therapeutics Inc. | PSTX | Lloyd Marcea Bland Director | 47,000 | $0 | 96,300 (Direct) | View |
| 2024-06-17 Option Award | 2024-06-18 4:15 pm | N/A 2034-06-16 | Poseida Therapeutics Inc. | PSTX | Corning Luke Director | 47,000 | $0 | 86,300 (Direct) | View |
| 2024-06-17 Option Award | 2024-06-18 4:14 pm | N/A 2034-06-16 | Poseida Therapeutics Inc. | PSTX | Collins Cynthia Director | 47,000 | $0 | 86,300 (Direct) | View |
| 2024-06-17 Option Award | 2024-06-18 4:13 pm | N/A 2034-06-16 | Poseida Therapeutics Inc. | PSTX | BAUM CHARLES M Director | 47,000 | $0 | 105,950 (Direct) | View |
| 2024-06-17 Option Award | 2024-06-18 4:12 pm | N/A 2034-06-16 | Poseida Therapeutics Inc. | PSTX | Amado Rafael Director | 47,000 | $0 | 86,300 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 4:03 pm | N/A 2034-03-31 | Poseida Therapeutics Inc. | PSTX | Rizvi Syed Ali-aamir Chief Medical Officer | 435,000 | $0 | 435,000 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-04 5:29 pm | N/A 2034-02-28 | Poseida Therapeutics Inc. | PSTX | Mylet Johanna Chief Financial Officer | 192,443 | $0 | 357,983 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-04 5:29 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Mylet Johanna Chief Financial Officer | 18,091 | $4.13 | 357,983 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-04 5:18 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Gergen Mark J Executive Chairman | 34,157 | $4.13 | 651,291 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-04 5:18 pm | N/A 2034-02-28 | Poseida Therapeutics Inc. | PSTX | LEONHARDT HARRY J GC & Chief Compliance Officer | 192,443 | $0 | 326,340 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-04 5:18 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | LEONHARDT HARRY J GC & Chief Compliance Officer | 16,306 | $4.13 | 326,340 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-04 5:18 pm | N/A 2034-02-28 | Poseida Therapeutics Inc. | PSTX | Warner Brent President, Gene Therapy | 192,443 | $0 | 530,740 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-04 5:18 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Warner Brent President, Gene Therapy | 35,739 | $4.13 | 530,740 (Direct) | View |
| 2024-02-01 Tax Withholding | 2024-02-02 8:51 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Gergen Mark J Executive Chairman | 47,162 | $3.41 | 685,448 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:03 pm | N/A 2034-01-01 | Poseida Therapeutics Inc. | PSTX | Yarema Kristin President and CEO | 595,200 | $0 | 952,036 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:02 pm | N/A 2034-01-01 | Poseida Therapeutics Inc. | PSTX | Gergen Mark J Executive Chairman | 297,600 | $0 | 905,210 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-16 4:10 pm | N/A 2033-06-14 | Poseida Therapeutics Inc. | PSTX | Collins Cynthia Director | 47,000 | $0 | 66,650 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-16 4:09 pm | N/A 2033-06-14 | Poseida Therapeutics Inc. | PSTX | Schmid John P. Director | 47,000 | $0 | 66,650 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-16 4:09 pm | N/A 2033-06-14 | Poseida Therapeutics Inc. | PSTX | Lloyd Marcea Bland Director | 47,000 | $0 | 76,650 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-16 4:08 pm | N/A 2033-06-14 | Poseida Therapeutics Inc. | PSTX | BAUM CHARLES M Director | 47,000 | $0 | 86,300 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-16 4:07 pm | N/A 2033-06-14 | Poseida Therapeutics Inc. | PSTX | Corning Luke Director | 47,000 | $0 | 66,650 (Direct) | View |
| 2023-05-01 Option Award | 2023-05-02 4:14 pm | N/A 2033-04-30 | Poseida Therapeutics Inc. | PSTX | Amado Rafael Director | 94,500 | $0 | 94,500 (Direct) | View |
| 2023-04-11 Option Award | 2023-04-12 4:49 pm | N/A 2033-04-10 | Poseida Therapeutics Inc. | PSTX | Yarema Kristin President, Cell Therapy | 855,161 | $0 | 855,161 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-02 6:30 pm | N/A 2033-02-28 | Poseida Therapeutics Inc. | PSTX | Warner Brent President, Gene Therapy | 218,055 | $0 | 499,319 (Direct) | View |
| 2023-03-01 Tax Withholding | 2023-03-02 6:30 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Warner Brent President, Gene Therapy | 26,617 | $5.35 | 499,319 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-02 6:28 pm | N/A 2033-02-28 | Poseida Therapeutics Inc. | PSTX | Mylet Johanna Chief Financial Officer | 218,055 | $0 | 302,914 (Direct) | View |
| 2023-03-01 Tax Withholding | 2023-03-02 6:28 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Mylet Johanna Chief Financial Officer | 4,323 | $5.35 | 302,914 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-02 6:26 pm | N/A 2033-02-28 | Poseida Therapeutics Inc. | PSTX | LEONHARDT HARRY J GC & Chief Compliance Officer | 218,055 | $0 | 269,486 (Direct) | View |
| 2023-03-01 Tax Withholding | 2023-03-02 6:26 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | LEONHARDT HARRY J GC & Chief Compliance Officer | 4,323 | $5.35 | 269,486 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-02 6:17 pm | N/A 2033-02-28 | Poseida Therapeutics Inc. | PSTX | Gergen Mark J President and CEO | 633,646 | $0 | 965,670 (Direct) | View |
| 2023-02-01 Tax Withholding | 2023-02-03 4:19 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Ostertag Eric Director | 11,776 | $7 | 6,028,560 (Direct) | View |
| 2023-02-01 Tax Withholding | 2023-02-03 4:16 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Gergen Mark J President and CEO | 31,819 | $7 | 330,314 (Direct) | View |
Ownership | 2023-01-17 9:18 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Ostertag Eric Director | 0 | $0 | 6,040,336 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-17 10:44 am | N/A 2032-06-15 | Poseida Therapeutics Inc. | PSTX | Collins Cynthia Director | 48,150 | $0 | 48,150 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-16 8:59 pm | N/A 2032-06-15 | Poseida Therapeutics Inc. | PSTX | BAUM CHARLES M Director | 96,300 | $0 | 96,300 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-16 8:57 pm | N/A 2032-06-15 | Poseida Therapeutics Inc. | PSTX | Corning Luke Director | 48,150 | $0 | 48,150 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-16 8:56 pm | N/A 2032-06-15 | Poseida Therapeutics Inc. | PSTX | Schmid John P. Director | 48,150 | $0 | 48,150 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-16 8:54 pm | N/A 2032-06-15 | Poseida Therapeutics Inc. | PSTX | Lloyd Marcea Bland Director | 48,150 | $0 | 58,150 (Direct) | View |